What is Utah Medical Products's 2029?

Utah Medical Products (UTMD) reported 2029 of $10K in Q4 2025.

How has Utah Medical Products's 2029 changed year-over-year?

Utah Medical Products's 2029 decreased by 28.6% year-over-year, from $14K to $10K.

What is the long-term trend for Utah Medical Products's 2029?

Over 5 years (2020 to 2025), Utah Medical Products's 2029 has grown at a -72.0% compound annual growth rate (CAGR), from $5.81M to $10K.

Utah Medical Products UTMD 2029

2029 at other companies

The Cooper Companies, Inc.COO

——

IAR

Integra LifeSciencesIART

——

UFP TechnologiesUFPT

——

InfuSystem HoldingsINFU

——

Medline, Inc. MDLN

——

ICU MedicalICUI

——

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's 2029.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's 2029?: Utah Medical Products (UTMD) reported 2029 of $10K in Q4 2025.
How has Utah Medical Products's 2029 changed year-over-year?: Utah Medical Products's 2029 decreased by 28.6% year-over-year, from $14K to $10K.
What is the long-term trend for Utah Medical Products's 2029?: Over 5 years (2020 to 2025), Utah Medical Products's 2029 has grown at a -72.0% compound annual growth rate (CAGR), from $5.81M to $10K.